Tag: Pharmaceutical Benefit Manager (PBM)
Mylan Loses Bid to Dismiss Class Action EpiPen Antitrust Lawsuit
Judge denies motion allowing lawsuit to continue.
Ruling Allows Millions to Join Lawsuit in EpiPen Racketeering Case
US District Judge Daniel Crabtree ruled numerous lawsuits against the marketer and manufacturer of EpiPen may proceed as a nationwide class-action under a federal racketeering statute.
Have You Paid $100 or More for an EpiPen? Here’s How...
Attorneys are working on a class-action lawsuit to seek justice for the strain rising EpiPen costs have put on people dealing with food allergies.
Mylan Accused of Secretly Maneuvering to Suppress Evidence in EpiPen Lawsuit
Mylan is accused of foul play in suppression of documents.
Kaléo Sued Over Evzio, an Auto-Injector With Pricing Structure Similar to...
Arcane system of pricing and insurance rebates at heart of the suit.
Sanofi Files Suit Against Mylan for Anti-Competitive EpiPen Strategy
More legal troubles for the embattled marketer of EpiPen.
A Deeper Look Into the Racketeering Lawsuit Against Mylan
The suit exposes a convoluted system that works to our detriment.
